GTS Securities’s Bristol-Myers Squibb BMY Stock Holding History

GTS Securities’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$372K	Sell	6,135 -13,152	-68%	-$767K	0.01%	954
2025 Q4	$1.04M	Buy	19,287 +11,042	+134%	+$531K	0.04%	431
2025 Q3	$372K	Sell	8,245 -7,068	-46%	-$330K	0.01%	905
2025 Q2	$709K	Sell	15,313 -18,644	-55%	-$915K	0.03%	504
2025 Q1	$2.07M	Buy	33,957 +14,046	+71%	+$819K	0.09%	170
2024 Q4	$1.13M	Sell	19,911 -152,846	-88%	-$8.54M	0.05%	303
2024 Q3	$8.94M	Sell	172,757 -123,325	-42%	-$5.79M	0.02%	558
2024 Q2	$12.3M	Buy	296,082 +103,781	+54%	+$4.64M	0.03%	418
2024 Q1	$10.4M	Sell	192,301 -70,279	-27%	-$3.58M	0.02%	490
2023 Q4	$13.5M	Buy	262,580 +154,833	+144%	+$8.13M	0.02%	484
2023 Q3	$6.25M	Buy	107,747 +65,881	+157%	+$4.04M	0.01%	813
2023 Q2	$2.68M	Buy	+41,866	New	+$2.81M	0.08%	223

Other funds holding BMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

GTS Securities's BMY Position: Q1 2026 in Review

GTS Securities reduced its Bristol-Myers Squibb (BMY) stake by 68% in Q1 2026, selling an estimated $767K and leaving 6,135 shares worth $372K. The position accounts for 0.01% of the portfolio, ranked #954.

GTS Securities first reported a position in BMY in Q2 2023 and has held it in 12 quarters since. The position peaked at $13.5M in Q4 2023. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

GTS Securities held 6,135 shares of Bristol-Myers Squibb worth $372K as of Q1 2026.
GTS Securities sold 13,152 Bristol-Myers Squibb shares in Q1 2026, an estimated $767K.
Bristol-Myers Squibb made up 0.01% of GTS Securities's portfolio in Q1 2026, its #954 holding.
GTS Securities first reported a position in Bristol-Myers Squibb in Q2 2023 and has held it in 12 quarters since.
GTS Securities's Bristol-Myers Squibb position peaked at $13.5M in Q4 2023.
2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on GTS Securities's 13F filing for Q1 2026, filed 15 May 2026.